Skip to main navigation Skip to search Skip to main content

High-Dose Oral and Intravenous Rifampicin for the Treatment of Tuberculous Meningitis in Predominantly Human Immunodeficiency Virus (HIV)-Positive Ugandan Adults: A Phase II Open-Label Randomized Controlled Trial

  • Fiona V. Cresswell
  • , David B. Meya
  • , Enock Kagimu
  • , Daniel Grint
  • , Lindsey Te Brake
  • , John Kasibante
  • , Emily Martyn
  • , Morris Rutakingirwa
  • , Carson M. Quinn
  • , Micheal Okirwoth
  • , Lillian Tugume
  • , Kenneth Ssembambulidde
  • , Abdu K. Musubire
  • , Ananta S. Bangdiwala
  • , Allan Buzibye
  • , Conrad Muzoora
  • , Elin M. Svensson
  • , Rob Aarnoutse
  • , David R. Boulware
  • , Alison M. Elliott

Research output: Contribution to journal › Article › peer-review

67   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'High-Dose Oral and Intravenous Rifampicin for the Treatment of Tuberculous Meningitis in Predominantly Human Immunodeficiency Virus (HIV)-Positive Ugandan Adults: A Phase II Open-Label Randomized Controlled Trial'. Together they form a unique fingerprint.
Sort by

Keyphrases

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science